Understanding how neuromelanin affects brain cell vulnerability in Alzheimer's disease
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease
This study is looking at how a substance called neuromelanin might affect certain brain cells in people with Alzheimer's disease, especially in a part of the brain that shows early signs of the condition, to help us understand why some symptoms like sleep problems and memory loss happen.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10525513 on NIH RePORTER |
What this research studies
This research investigates the role of neuromelanin in the vulnerability of specific brain neurons in Alzheimer's disease. It focuses on the locus coeruleus, a brain region that shows early signs of Alzheimer's pathology, such as changes in tau proteins and neuron loss. By using a viral vector to produce human tyrosinase in mice, the study aims to explore how neuromelanin contributes to neuron dysfunction and the associated symptoms of Alzheimer's, including sleep disturbances and cognitive decline. The findings could provide insights into the mechanisms of Alzheimer's and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those experiencing early symptoms such as sleep disturbances or cognitive changes.
Not a fit: Patients with advanced Alzheimer's disease or those without any symptoms of cognitive decline may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating cognitive and sleep-related symptoms in Alzheimer's disease.
How similar studies have performed: While the specific approach of investigating neuromelanin in this context is novel, related research has shown promise in understanding the role of brain chemistry in neurodegenerative diseases.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Weinshenker, David — Emory University
- Study coordinator: Weinshenker, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.